Advertisement

Topics

Adynxx Agrees to Merger with Alliqua to Gain Public Stock Listing

10:25 EDT 12 Oct 2018 | Xconomy

The number of biotech companies completing an IPO has swelled this year and Adynxx aims to join their ranks—but through an alternate path. The pain drug developer has agreed to combine operations with publicly traded Alliqua Biomedical. Under the merger agreement announced Friday, shares of Adynxx will convert into Alliqua (NASDAQ: ALQA) stock, leaving former […]

Original Article: Adynxx Agrees to Merger with Alliqua to Gain Public Stock Listing

NEXT ARTICLE

More From BioPortfolio on "Adynxx Agrees to Merger with Alliqua to Gain Public Stock Listing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...